Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Dermatology | Family Medicine | Internal Medicine | Nursing | Oncology | Pathology | Conference News

Back to Journal Articles

AACR: Coffee Tied to Lower Basal Cell Carcinoma Risk

Last Updated: October 25, 2011.

 

Inverse link between coffee intake and basal cell, not squamous cell carcinoma or melanoma risk

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
There is an inverse relationship between caffeinated coffee consumption and the risk of basal cell carcinoma, but not squamous cell carcinoma and melanoma, according to a study presented at the American Association for Cancer Research's International Conference on Frontiers in Cancer Prevention Research, held from Oct. 22 to 25 in Boston.

TUESDAY, Oct. 25 (HealthDay News) -- There is an inverse relationship between caffeinated coffee consumption and the risk of basal cell carcinoma (BCC), but not squamous cell carcinoma (SCC) and melanoma, according to a study presented at the American Association for Cancer Research's International Conference on Frontiers in Cancer Prevention Research, held from Oct. 22 to 25 in Boston.

Fengju Song, Ph.D., from the Brigham and Women's Hospital in Boston, and colleagues investigated the relationship between coffee consumption and risk of BCC, SCC, and melanoma. Data were collected from 72,921 participants in the Nurses' Health Study, and 39,976 participants in the Health Professionals Follow-up Study. A total of 25,480 incident skin cancer cases were identified. The relative risks were calculated after adjusting for confounding variables and skin cancer risk factors.

The investigators found that coffee consumption was inversely associated with BCC risk, with a significant dose-response relationship for both men and women. Drinking more than three cups of coffee daily versus less than one cup per month was associated with a relative risk (RR) of 0.80 (95 percent confidence interval [CI], 0.75 to 0.85) in women and 0.91 (95 percent CI, 0.81 to 1.02) in men. The amount of caffeine consumed correlated inversely with BCC risk, with individuals in the highest consumption quintile having the lowest risk (RRs, 0.82 and 0.87 for women and men, respectively). Consumption of decaffeinated coffee did not correlate with lower BCC risk. There was no inverse association between coffee consumption and SCC or melanoma.

"Coffee consumption is inversely associated with BCC risk in women and men, likely through the effect of caffeine," the authors write.

Press Release
More Information

Copyright © 2011 HealthDay. All rights reserved.


Previous: AACR: NSAID Use Tied to Lower Colorectal Cancer Mortality Next: Mortgage Default Associated With Worse Health Status

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.